LC
JRMM
AG
MH
DBLTJJPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Beacontxbeacontx.com  XL DCNJ |
Beacon Therapeutics is a clinical-stage biotechnology company developing AAV gene therapy treatments to save and restore sight in | — | — | — |
Adverum Biotechnologiesadverum.com  DV MRRG |
Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage biotechnology company developing Ixo-vec, an investigational AAV gene t | Redwood City, California | 51-200 | — |
Nightstarxnightstarx.com |
— | — | — | |
Jcyjcy.com |
— | — | — | |
REGENXBIOregenxbio.com AK  SP JB |
REGENXBIO is a clinical-stage biotechnology company founded in 2008 and headquartered in Rockville, Maryland, pioneering AAV gene | Rockville, Maryland | 201-1000 | — |
Sparktherapeuticssparktherapeutics.com |
— | — | — | |
Uniquestxuniquestx.com |
— | — | — | |
Avexisavexis.com |
— | — | — | |
Pregenenbluebirdbio.com |
Genetix Biotherapeutics (formerly bluebird bio) is a privately held, Boston-area gene therapy company developing first-in-class, o | Seattle, Washington | 1-10 | — |
Unique Mindsuniqueminds.com RW  CC ST |
Unique Minds is a software development company founded in 2024 in Redmond, Washington, that integrates artificial intelligence to | Redmond, Washington | 1-10 | — |
uniQureuniqure.com  MWJL WA |
uniQure is a gene therapy company with a modular, validated technology platform that advances a pipeline of proprietary and partne | Amsterdam, 1105BP | 201-1000 | — |
Blueprint Medicinesblueprintmedicines.com MRZCAM |
Blueprint Medicines, a Sanofi company, is a fully integrated global biopharmaceutical company that invents life-changing medicines | Cambridge, Massachusetts | 201-1000 | — |
Aveyxaveyx.com |
— | — | — | |
Crispagencrispagen.com |
— | — | — | |
Crispatherapeuticscrispatherapeutics.com |
— | — | — | |
Beam Therapeuticsbeamtx.com |
Beam Therapeutics is a CRISPR base editing biotechnology company founded in 2017 and headquartered in Cambridge, MA, developing a | Cambridge, Massachusetts | 201-1000 | — |
Editas Medicineeditasmedicine.com |
Editas Medicine is a clinical-stage genome editing company that develops CRISPR-based medicines for serious diseases, with a pipel | Cambridge, Massachusetts | 51-200 | — |
Regenxregenx.com |
— | — | — | |
Avextxavextx.com |
— | — | — | |
Meirameira.com |
— | — | — | |
Genetherapysolutionsgenetherapysolutions.com |
— | — | — | |
Genzymegenzyme.com |
— | — | — | |
Bluejaytherapeuticsbluejaytherapeutics.com |
— | — | — | |
Genetherapysciencesgenetherapysciences.com |
— | — | — | |
Allogene Therapeuticsallogene.com |
Allogene Therapeutics is a clinical-stage biotechnology company developing investigational allogeneic chimeric antigen receptor T | South San Francisco, California | 201-1000 | — |
Homologytxhomologytx.com |
— | — | — | |
Orchardtherapeuticsorchardtherapeutics.com |
— | — | — | |
Adaptimmuneadaptimmune.com |
Adaptimmune (ADAPY) is a biopharmaceutical company developing cell therapies to treat cancer, with its announced product TECELRA ( | — | — | — |
4Dmtx4dmtx.com |
— | — | — | |
Homologymedicinehomologymedicine.com |
— | — | — | |
| Run live for more | ||||
Beacon Therapeutics is a clinical-stage biotechnology company developing AAV gene therapy treatments to save and restore sight in people with rare and prevalent blinding ocular diseases, including X-Linked Retinitis Pigmentosa (XLRP), Cone Rod Dystrophy (CRD), and Geographic Atrophy.
Companies like Beacontx include Adverum Biotechnologies, Nightstarx, Jcy, REGENXBIO, Sparktherapeutics. See the full list of 24 competitors and alternatives above.
Key decision-makers and buying contacts at Beacontx are listed above, including leaders across executive, finance, sales and operations.